Literature DB >> 15655533

Role of SK(Ca) and IK(Ca) in endothelium-dependent hyperpolarizations of the guinea-pig isolated carotid artery.

Pascale Gluais1, Gillian Edwards, Arthur H Weston, John R Falck, Paul M Vanhoutte, Michel Félétou.   

Abstract

1. This study was designed to determine whether the endothelium-dependent hyperpolarizations evoked by acetylcholine in guinea-pig carotid artery involve a cytochrome P450 metabolite and whether they are linked to the activation of two distinct populations of endothelial K(Ca) channels, SK(Ca) and IK(Ca.) 2. The membrane potential was recorded in the vascular smooth muscle cells of the guinea-pig isolated carotid artery. All the experiments were performed in the presence of N(omega)-L-nitro arginine (100 microM) and indomethacin (5 microM). 3. Under control conditions (Ca(2+): 2.5 mM), acetylcholine (10 nM to 10 muM) induced a concentration- and endothelium-dependent hyperpolarization of the vascular smooth muscle cells. Two structurally different specific blockers of SK(Ca), apamin (0.5 microM) or UCL 1684 (10 microM), produced a partial but significant inhibition of the hyperpolarization evoked by acetylcholine whereas charybdotoxin (0.1 microM) and TRAM-34 (10 microM), a nonpeptidic and specific blocker of IK(Ca), were ineffective. In contrast, the combinations of apamin plus charybdotoxin, apamin plus TRAM-34 (10 microM) or UCL 1684 (10 microM) plus TRAM-34 (10 microM) virtually abolished the acetylcholine-induced hyperpolarization. 4. In the presence of a combination of apamin and a subeffective dose of TRAM-34 (5 microM), the residual hyperpolarization produced by acetylcholine was not inhibited further by the addition of either an epoxyeicosatrienoic acid antagonist, 14,15-EEZE (10 microM) or the specific blocker of BK(Ca), iberiotoxin (0.1 microM). 5. In presence of 0.5 mM Ca(2+), the hyperpolarization in response to acetylcholine (1 microM) was significantly lower than in 2.5 mM Ca(2+). The EDHF-mediated responses became predominantly sensitive to charybdotoxin or TRAM-34 but resistant to apamin. 6. This investigation shows that the production of a cytochrome P450 metabolite, and the subsequent activation of BK(Ca), is unlikely to contribute to the EDHF-mediated responses in the guinea-pig carotid artery. Furthermore, the EDHF-mediated response involves the activation of both endothelial IK(Ca) and SK(Ca) channels, the activation of either one being able to produce a true hyperpolarization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655533      PMCID: PMC1576024          DOI: 10.1038/sj.bjp.0706003

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  48 in total

Review 1.  Ion channels and their functional role in vascular endothelium.

Authors:  B Nilius; G Droogmans
Journal:  Physiol Rev       Date:  2001-10       Impact factor: 37.312

Review 2.  EDHF: bringing the concepts together.

Authors:  Rudi Busse; Gillian Edwards; Michel Félétou; Ingrid Fleming; Paul M Vanhoutte; Arthur H Weston
Journal:  Trends Pharmacol Sci       Date:  2002-08       Impact factor: 14.819

3.  Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF.

Authors:  Rostislav Bychkov; Matthew P Burnham; Gillian R Richards; Gillian Edwards; Arthur H Weston; Michel Félétou; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

4.  Mechanism of calcium gating in small-conductance calcium-activated potassium channels.

Authors:  X M Xia; B Fakler; A Rivard; G Wayman; T Johnson-Pais; J E Keen; T Ishii; B Hirschberg; C T Bond; S Lutsenko; J Maylie; J P Adelman
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

5.  Inhibition of EDHF by two new combinations of K+-channel inhibitors in rat isolated mesenteric arteries.

Authors:  Jane M Hinton; Philip D Langton
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  Further investigations into the endothelium-dependent hyperpolarizing effects of bradykinin and substance P in porcine coronary artery.

Authors:  G Edwards; M Félétou; M J Gardener; C D Glen; G R Richards; P M Vanhoutte; A H Weston
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

7.  14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries.

Authors:  Kathryn M Gauthier; Christina Deeter; U Murali Krishna; Y Krishna Reddy; Muralidhar Bondlela; J R Falck; William B Campbell
Journal:  Circ Res       Date:  2002-05-17       Impact factor: 17.367

8.  Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF.

Authors:  M P Burnham; R Bychkov; M Félétou; G R Richards; P M Vanhoutte; A H Weston; G Edwards
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

9.  Selective blockade of endothelial Ca2+-activated small- and intermediate-conductance K+-channels suppresses EDHF-mediated vasodilation.

Authors:  Ines Eichler; Judith Wibawa; Ivica Grgic; Andrea Knorr; Susanne Brakemeier; Axel R Pries; Joachim Hoyer; Ralf Köhler
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

10.  Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure.

Authors:  Mark S Taylor; Adrian D Bonev; Tobias P Gross; Delrae M Eckman; Joseph E Brayden; Chris T Bond; John P Adelman; Mark T Nelson
Journal:  Circ Res       Date:  2003-06-12       Impact factor: 17.367

View more
  29 in total

1.  Potentiation of EDHF-mediated relaxation by chloride channel blockers.

Authors:  Cui Yang; Yiu-wa Kwan; Shun-wan Chan; Simon Ming-yuen Lee; George Pak-heng Leung
Journal:  Acta Pharmacol Sin       Date:  2010-09-13       Impact factor: 6.150

2.  Inhibition of SK and M channel-mediated currents by 5-HT enables parallel processing by bursts and isolated spikes.

Authors:  Tara Deemyad; Leonard Maler; Maurice J Chacron
Journal:  J Neurophysiol       Date:  2011-01-05       Impact factor: 2.714

3.  KIR channels function as electrical amplifiers in rat vascular smooth muscle.

Authors:  Pamela D Smith; Suzanne E Brett; Kevin D Luykenaar; Shaun L Sandow; Sean P Marrelli; Edward J Vigmond; Donald G Welsh
Journal:  J Physiol       Date:  2007-12-06       Impact factor: 5.182

Review 4.  Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Authors:  Michel Félétou
Journal:  Br J Pharmacol       Date:  2009-01-29       Impact factor: 8.739

5.  Characteristics of ACh-induced hyperpolarization and relaxation in rabbit jugular vein.

Authors:  Takeo Itoh; Takashi Maekawa; Yasushi Shibayama
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

6.  TRPM8 channel activation triggers relaxation of pudendal artery with increased sensitivity in the hypertensive rats.

Authors:  Darizy Flavia Silva; Camilla Ferreira Wenceslau; Cameron G Mccarthy; Theodora Szasz; Safia Ogbi; R Clinton Webb
Journal:  Pharmacol Res       Date:  2019-07-21       Impact factor: 7.658

7.  Acute activation of endothelial AMPK surprisingly inhibits endothelium-dependent hyperpolarization-like relaxations in rat mesenteric arteries.

Authors:  Hui Chen; Paul M Vanhoutte; Susan W S Leung
Journal:  Br J Pharmacol       Date:  2019-07-04       Impact factor: 8.739

Review 8.  Vascular TRP channels: performing under pressure and going with the flow.

Authors:  David C Hill-Eubanks; Albert L Gonzales; Swapnil K Sonkusare; Mark T Nelson
Journal:  Physiology (Bethesda)       Date:  2014-09

Review 9.  Endothelium-derived hyperpolarising factors and associated pathways: a synopsis.

Authors:  Gillian Edwards; Michel Félétou; Arthur H Weston
Journal:  Pflugers Arch       Date:  2010-04-11       Impact factor: 3.657

10.  Sex differences in endothelial function in porcine coronary arteries: a role for H2O2 and gap junctions?

Authors:  P S Wong; R E Roberts; M D Randall
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.